It is not clear, however milestone increments in fee percentages are usually for amounts above milestones (eg. Sales $300M: fees $25M + $6M). The better payment is the milestone lump sum of $50M when sales achieve $250M, that is 25% of the milestone sales figure and is generous, but all lump sums are one-off.
There will be some misalignment with 'Annual Net Sales' and 'Net Sales in one calendar year' if it goes to the market in April, so the first lump sum won't be available until the end of 2024 now.
Great to see this product arrive with approval from Prof. Dame Brimble's experimenting ... and hopefully more associated products to come that fend off neurodegenerative disorders.
- Forums
- ASX - By Stock
- NEU
- Ann: FDA approves Daybue - the first treatment for Rett syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.69%
!
$14.20

Ann: FDA approves Daybue - the first treatment for Rett syndrome, page-73
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B |
Open | High | Low | Value | Volume |
$13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $14.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.23 | 3278 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1300 | 14.030 |
1 | 500 | 14.000 |
1 | 357 | 13.970 |
1 | 30 | 13.900 |
1 | 700 | 13.700 |
Price($) | Vol. | No. |
---|---|---|
14.260 | 2920 | 1 |
14.300 | 1000 | 1 |
14.380 | 72 | 1 |
14.400 | 1000 | 1 |
14.460 | 434 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online